| PERIOD ENDING | 1-Nov-09 | 2-Aug-09 | 30-Apr-09 | 1-Feb-09 | | Total Revenue | 145,730 | 128,725 | 116,664 | 136,355 | | Cost of Revenue | 103,552 | 99,323 | 87,011 | 95,196 | | | Gross Profit | 39,793 | 29,402 | 29,653 | 41,159 | | | Operating Expenses | | Research Development | 21,575 | 21,047 | 22,318 | 24,098 | | Selling General and Administrative | 15,490 | 16,440 | 16,136 | 19,446 | | Non Recurring | 4,173 |
-
| 13,205 | 46,534 | | Others | 2,903 | 701 | 824 | 841 | | | | Total Operating Expenses | 44,141 |
-
| 52,483 | 90,919 | | | | Operating Income or Loss | (1,963) | (8,786) | (22,830) | (49,760) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (27,249) | 263 | 3 | 3,440 | | Earnings Before Interest And Taxes | (29,212) | (8,523) | (22,827) | (46,320) | | Interest Expense | 2,167 | 2,434 | 1,332 | 1,469 | | Income Before Tax | (31,379) | (10,957) | (24,159) | (47,789) | | Income Tax Expense | 38 | 159 | 467 | (432) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (31,417) | (11,116) | (24,626) | (47,357) | | | Non-recurring Events | | Discontinued Operations | (67) | 37,079 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (31,484) | 25,963 | (24,626) | (47,357) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($31,484) | $25,963 | ($24,626) | ($47,357) |
|
0.10% Nasdaq 0.00%
Income Statement
